Skip to main content
. 2003 Apr;87(4):423–431. doi: 10.1136/bjo.87.4.423

Table 3.

Patient characteristics, previous therapies, and course of IFN therapy

No Previous therapy Start IFN Stop IFN Reason stop IFN Number of ocular relapses
1 Ster, CSA Mar 95 Jun 97 CR 0
2 Ster, AZA Nov 95 Sep 00 CR 2
3 Ster, Col, IFNγ Nov 95 0
4 Ster, AZA Dec 96 Nov 99 CR 0
5 Ster Aug 96 May 97 CR 0
6 Ster, MTX Oct 96 15
7 Ster, CSA, AZA Sep 96 Jan 98 CR 1
8 Ster, CSA Mar 97 Jan 00 CR 0
9 Ster, MTX May 97 Jul 98 CR 0
10 Ster, CSA May 97 Jul 98 CR 0
11 Ster, CSA Mar 97 0
12 Ster, AZA Apr 97 0
13 Ster Mar 97 Mar 98 CR 0
14 Ster Nov 97 Feb 99 CR 0
15 Ster Nov 97 Dec 98 CR 0
16 Ster Oct 97 0
17 Ster, CSA Nov 98 Nov 99 noncompl (CR), AZA ineff 0
18 Ster, AZA Jun 97 May 98 CR (eye), lost to follow up
19 Ster, AZA, CSA Dec 95 Jan 97 Ineff
20 Ster, MMF Jul 99 0
21 Ster Apr 99 0
22 Ster, CSA May 99 0
23 none May 99 Aug 00 CR (noncompl), lost to follow-up
24 Ster, AZA, CSA Dec 98 0
25 Ster, CSA Mar 99 0
26 Ster, CSA, Cy, AZA May 97 Feb 98 ineff (Cy, ineff)
27 Ster, CSA, Cy, Jun 97 Dec 97 side eff (CR), (Aza ineff)
28 Ster, CSA Oct 97 Oct 98 CR 0
29 Ster, CSA, Cy Dec 97 May 98 ineff (Cy, Aza ineff)
30 Ster, CSA Aug 96 Feb 97 side eff (PR) 0
31 Ster Col Dec 96 Jun 97 CR, lost to follow up 0
32 Ster, AZA Jan 96 Jun 96 CR 0
33 Ster AZA Aug 97 Aug 98 CR, died in car acc
34 none Sep 96 Dec 97 CR 0
35 Ster, CSA Oct 96 Sep 97 add IFNγ
36 Ster, AZA, CSA Jun 99 0
37 Ster, AZA Apr 99 Jan 00 CR 0
38 Ster Aug 99 0
39 Ster, AZA Mar 99 Jun 99 CR, pathergy pos 0
40 Ster Oct 99 1
41 Ster, CSA Aug 99 1
42 Ster, CSA Sep 99 0
43 Ster Jan 00 0
44 none Jan 00 0
45 Ster, AZA Feb 00 0
46 Ster, MTX, CSA Jan 00 0
47 Ster, CSA, Chloramb Mar 00 0
48 Ster Aug 97 0
49 Ster, MTX, Cy Dec 98 0
50 Ster May 98 Jan 00 CR 1

Ster = steroids; CSA = cyclosporin A; AZA = azathioprine; MTX = methotrexate; Cy = cyclophosphamide; Chloramb = chlorambucil; MMF = mycophenolate mofetil; Col = colchicine; CR = complete remission; noncompl = noncompliance.